Cookie Policy - To find out more about cookies on this website, see our privacy policy

Cookie Policy

We Help Companies Find New Sales Opportunities

We Help Companies Find New Sales Opportunities

Strakan Group

Strakan has acquired Elfar, the Spanish pharmaceuticals distribution company with 45 staff, for undisclosed terms.

Strakan has raised £22m from investors to fund the expansion of its Borders-based pharmaceuticals business, and is interested in product and corporate acquisitions.

Strakan Pharmaceuticals is to merge with Proskelia of France, in order to create a combined skin, bone and hormone disorder company with a valuation of £200m.

Strakan Group has raised £30m in a private equity investment to fund the development of new drugs for bone and skin disease, and expects to create about 20 jobs at its Galashiels base.

Strakan Group, the Galashiels-based developer of prescription medicines, has received a £11m cash injection from a syndicate of investors and hopes to double the size of its 22-strong workforce over the next two years.